Advertisement

Rheumatology International

, Volume 28, Issue 9, pp 935–937 | Cite as

Henoch–Schonlein purpura with high factor VIII levels and deep venous thrombosis: an association or coincidence?

  • Rezan Topaloglu
  • Umut Selda BayrakciEmail author
  • Barbaros Cil
  • Diclehan Orhon
  • Aysin Bakkaloglu
Case Report

Abstract

Henoch–Schonlein purpura (HSP) is the most common systemic vasculitis in children. Although long-term outcome is generally good, serious complications may occur. Thrombosis has been reported only as an extremely rare complication of HSP. Here, we describe a 15-year-old-boy with features of HSP, who developed left main iliac, external iliac and femoral vein thrombosis. Factor VIII (FVIII) and homocystein levels were found to be high. This suggests that HSP itself may lead to a prothrombotic state and increase the risk of developing thrombosis in patients who have any risk factors.

Keywords

Henoch–Schonlein purpura Thrombosis Factor VIII Childhood 

References

  1. 1.
    Garber ME, Mahr BE, Calabrese LH (1993) Henoch–Schonlein purpura associated with anti-Ro (SSA) and antiphospholipid antibody syndrome. J Rheumatol 20:1964–1966PubMedGoogle Scholar
  2. 2.
    Sokol DK, Mclntyre JA, Short RA, Gutt J, Wagenknecht DR, Biller J, Garg B (2000) Henoch–Schonlein purpura and stroke: antiphosphatdylethanolamine antibody in CSF and serum. Neurology 55:1379–1381PubMedGoogle Scholar
  3. 3.
    Sari I, Akar S, Secil M, Birlik M, Kefi A, Onen F, Celebi I, Akkoc N (2005) Thrombosis and priapism in a patient with Henoch–Schonlein purpura. Rheumatol Int 25:472–474PubMedCrossRefGoogle Scholar
  4. 4.
    Kamitsuji H, Tani K, Yasui M, Taniguchi A, Taira K, Tsukada S, Iida Y, Kanki H, Fukui H (1987) Activity of blood coagulation factor XIII as a prognostic indicator in patients with Henoch–Schonlein purpura. Eur J Pediatr 146:519–523PubMedCrossRefGoogle Scholar
  5. 5.
    Culic S, Jakl R, Metlicic V, Paukovic-Sekulic B, Resic B, Culic V, Kuljis D, Primorac D (2001) Platelet function analysis in children with Schonlein–Henoch syndrome. Arch Med Res 32:268–272PubMedCrossRefGoogle Scholar
  6. 6.
    De Mattia D, Penza R, Giardano P, Del Vecchio GC, Aceto G, Altomare M, Schettini F (1995) von Willebrand factor and factor XIII in children with Henoch–Schonlein purpura. Pediatr Nephrol 9:603–605PubMedCrossRefGoogle Scholar
  7. 7.
    Prandota J, Pankow-Prandota L, Kotecki L (2001) Impaired activation of the fibrinolytic system in children with Henoch–Schonlein purpura: beneficial effect of hydrocortisone plus Sigma-aminocaproic acid therapy on disappearance rate of cutaneous vasculitis and fibrinolysis. Am J Ther 8:11–19PubMedCrossRefGoogle Scholar
  8. 8.
    Brendel-Muller K, Hahn A, Schneppenheim R, Santer R (2001) Laboratory signs of activated coagulation is common in Henoch-purpura. Pediatr Nephrol 16:1084–1088PubMedCrossRefGoogle Scholar
  9. 9.
    Besbas N, Erbay A, Saatci U (1998) Thrombomodulin, tissue plasminogen activator and plasminogen activator inhibitor-1 in Henoch-purpura. Clin Exp Rheumatol 16:95–98PubMedGoogle Scholar
  10. 10.
    Yilmaz D, Kavakli K, Ozkayin N (2005) The elevated markers of hypercoagulability in childrenwith Henoch–Schonlein purpura. Pediatr Hematol Oncol 22:41–48PubMedCrossRefGoogle Scholar
  11. 11.
    Ates E, Bakkaloglu A, Saatci U, Soylemezoglu O (1994) von Willebrand factor antigen compared with other factors in vasculitic syndromes. Arch Dis Child 70:40–43PubMedCrossRefGoogle Scholar
  12. 12.
    Kiraz S, Ertemli I, Ozturk MA, Haznedaroglu IC, Celik I, Calguneri M (2002) Pathological Haemostasis and ‘protrombotic state’ in Behcet’s Disease. Thromb Res 105:125–133PubMedCrossRefGoogle Scholar
  13. 13.
    Kurekci AE, Gokce H, Akar N (2003) Factor VIII levels in children with thrombosis. Pediatr Int 45:159–162PubMedCrossRefGoogle Scholar
  14. 14.
    Rosendaal FR (2000) High levels of factor VIII, venous thrombosis. Thromb Haemost 83:1–2PubMedGoogle Scholar
  15. 15.
    Selhub J, D’Angelo A (1997) Hyperhomocysteinemia and thrombosis: Acquired conditions. Thromb Haemost 78:527–531PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Rezan Topaloglu
    • 1
  • Umut Selda Bayrakci
    • 1
    • 4
    Email author
  • Barbaros Cil
    • 2
  • Diclehan Orhon
    • 3
  • Aysin Bakkaloglu
    • 1
  1. 1.Department of Pediatric Nephrology and Rheumatology, Faculty of MedicineHacettepe UniversityAnkaraTurkey
  2. 2.Department of Radiology, Faculty of MedicineHacettepe UniversityAnkaraTurkey
  3. 3.Department of Pediatric Pathology, Faculty of MedicineHacettepe UniversityAnkaraTurkey
  4. 4.Pediatrik Nefroloji Unitesi, Tıp FakültesiBaskent UniversitesiBahcelievler, AnkaraTurkiye

Personalised recommendations